Peptiholic — a peptide-science knowledge hub by Panacea Bio Chem and Bogdan DicoiasPanacea Bio Chem · Knowledge Hub
Peptide Science
Updated Jul 2026
Peptide Science · Explained · Knowledge Hub

Peptide science, explained: what peptides are, how they work, and how quality is assured

A friendly, honest entry point to the world of peptides — from the amino-acid building blocks up to the classes of peptide medicines, and the care that keeps a fragile chain intact from synthesiser to dose.

2–50
amino acids in a typical peptide chain
1 bond
the peptide bond links each residue
20
standard amino-acid "letters" of the alphabet
80+
peptide medicines in use worldwide
Archival record of biologically active peptide research — the science this peptide knowledge hub explains; Panacea Bio Chem, by Bogdan Dicoias
Peptide science has a long, patient history of researchers decoding how short amino-acid chains carry the body's messages. This peptide knowledge hub — a Panacea Bio Chem resource by Bogdan Dicoias — gathers the essentials in one place.
In brief

A peptide is a short chain of amino acids joined by peptide bonds — smaller than a protein, larger than a single amino acid. Many peptides act as the body's messengers: their exact sequence gives them a shape that fits a specific receptor, switching a biological process on or off. This hub explains, in plain language, what peptides are, how they work, the main classes and uses, and how peptide quality is assured — then points to where Panacea Bio Chem researches the frontier: keeping a fragile chain intact all the way to the dose. It is a scientific description, not medical advice.

1.  What is a peptide? — start here

Picture the twenty standard amino acids as letters in an alphabet. String a few of them together and you spell a short word: that word is a peptide. Each link between two amino acids is a peptide bond — a strong chemical join formed when the acid end of one amino acid meets the amine end of the next, releasing a molecule of water. A chain of two to roughly fifty amino acids is generally called a peptide; longer chains that fold into a fixed three-dimensional shape become proteins1. So a peptide sits neatly in the middle: small enough to design and build with precision, yet large enough to carry a specific, meaningful biological message.

The order of the letters is everything. Swap one amino acid for another and you can change the peptide's shape, and therefore what it does — the same way changing one letter turns one word into a different one. This is why peptide science begins with sequence: the sequence sets the fold, the fold sets the function. Understanding that single idea — sequence → shape → function — unlocks almost everything else on this page.

Amino acid

A single building block. Twenty standard kinds, each with its own chemical personality (some water-loving, some water-fearing, some charged).

Peptide bond

The join between two amino acids. A row of these bonds forms the peptide's flexible "backbone".

Peptide

A short chain (roughly 2–50 residues). Often flexible, frequently a signalling molecule.

Protein

A longer chain that folds into a defined shape to do a job — an enzyme, an antibody, a structural fibre.

The peptide-versus-protein boundary is a convention, not a hard line. Insulin, at 51 amino acids, is called both a small protein and a peptide hormone — and nobody minds.

2.  How peptides work — the body's messengers

A key that fits one lock

Many peptides are signalling molecules. A cell or gland releases a peptide; it travels through blood or tissue until it reaches a matching receptor on a target cell. Because the peptide's sequence gives it a precise shape, it fits that receptor like a key in a lock — and turning the key switches a process on or off. Insulin tells cells to take up glucose. Glucagon-like peptide-1, a gut hormone, prompts insulin release, calms appetite and slows the stomach — the biology behind a whole class of modern GLP-1 receptor-agonist medicines →. Neuropeptides carry messages between neurons; immune peptides coordinate defence; antimicrobial peptides guard the skin.

This lock-and-key specificity is exactly why peptides are such an appealing basis for medicines. A well-designed peptide can act on one target with a light touch, then be broken down into ordinary amino acids the body already knows how to handle. That combination — high specificity, high potency, gentle breakdown — is what draws so much research to the peptide space.

Sequence sets the shape; shape sets the function. Master that one idea and peptides stop being mysterious.

There is a catch, and it shapes the whole field: peptides are fragile. The same flexibility that lets them fit a receptor also lets them unfold, clump together, or be snipped apart by enzymes in minutes. Left in the wrong conditions they can oxidise or lose their shape. So the story of peptide medicines is really two stories — designing a chain that does the right thing, and keeping that chain intact long enough to reach its target. The second story is where preservation science, and much of Panacea's work, lives.

Molecular models used in science education to visualise chemical structure — the shape-thinking behind peptide science; Panacea Bio Chem, Bogdan Dicoias
Ball-and-stick models make an invisible idea tangible: a peptide's shape is what a receptor actually "sees". Thinking in shapes is the heart of peptide science — a habit this Panacea Bio Chem hub, by Bogdan Dicoias, tries to pass on.

3.  Peptide classes & uses — a field guide

Peptides are wonderfully varied. Grouping them by the job they do is the quickest way to make sense of the field. The table below is a friendly map, not an exhaustive list — each row is a family a curious reader can then explore in depth.

Major peptide classes and what they do
ClassWhat it doesFamiliar example
Peptide hormonesCarry chemical messages between glands and organs to tune metabolism, growth and appetiteInsulin · GLP-1 · oxytocin
NeuropeptidesSignal between neurons; shape mood, pain, sleep and hungerEndorphins · orexin
Antimicrobial peptidesPart of innate defence; disrupt microbes and support the skin barrierDefensins · cathelicidins
Immune / cytokine-likeCoordinate immune cells and inflammation signallingInterleukin fragments
Structural peptidesBuild and repair tissue scaffolds and matricesCollagen peptides
Research & designer peptidesEngineered sequences made to study biology or to serve as therapeutic candidatesCustom-synthesised chains

Their uses follow their jobs. Peptide hormones underpin metabolic medicines; antimicrobial peptides inspire new anti-infectives; structural peptides appear in wound care and cosmetics; and engineered designer peptides → are drawn residue by residue for a specific target. Across all of them runs one shared theme: a peptide is only as useful as it is intact when it arrives.

4.  How peptide quality is assured

If sequence is everything, then making the exact right sequence — and proving you did — is the whole game of peptide quality. Three questions matter: did we build the correct chain, is it pure, and is it still whole?

  1. Build it, one residue at a time. Modern peptides are assembled by solid-phase peptide synthesis2 — the chain grows while anchored to a tiny resin bead, adding one amino acid per cycle in a controlled, repeatable order.
  2. Purify it. The raw product is separated from by-products, usually by high-performance liquid chromatography (HPLC), until the target peptide is isolated to high purity.
  3. Prove its identity. Mass spectrometry weighs the molecule to confirm the right chain was made; sequence checks confirm the residues are in the right order.
  4. Keep it intact. A correct, pure peptide can still degrade on the shelf — oxidising, aggregating or absorbing moisture. Preserving it through gentle drying and careful storage is a distinct discipline, and the last, decisive step of quality.

That final step is easy to overlook and hard to master. A peptide that leaves the synthesiser perfect but arrives at the clinic partly unfolded has failed just as surely as one made wrong. This is why so much of the frontier — and so much of Panacea's research — concentrates on the last mile: gentle Cryolapse lyophilization →, raising the temperature at which a dried cake stays stable with TgShift →, and sealing an active away from the oxygen and trace metals that quietly age it with RedoxVault →.

5.  The story — the day peptides became buildable

A true origin story

For the first half of the twentieth century, making a specific peptide by hand was painstaking chemistry — every join formed and cleaned in solution, step after fragile step. Then, in 1963, a young Rockefeller University biochemist named Robert Bruce Merrifield proposed something that sounded almost too simple: what if you anchored the growing chain to a tiny insoluble bead and added the amino acids one at a time, washing away the leftovers after each cycle?3

Colleagues were sceptical — but solid-phase peptide synthesis turned peptide-making from a rare art into something like an assembly line. It could be automated; a chain that once took months could be built in days. Merrifield received the 1984 Nobel Prize in Chemistry for the idea. Nearly every research peptide, and a great many peptide medicines, are made on his descendants today — the reason a precisely defined peptide can now be ordered, built and checked at all. The breakthrough was not a new molecule; it was a new way to make molecules, reliably enough to trust. It is the quiet foundation the rest of this hub stands on.

6.  Where Panacea Bio Chem researches

Panacea Bio Chem researches the therapeutic-peptide sphere — and treats one problem as its focus: keeping a fragile peptide chain intact all the way from synthesiser to dose. Where the field has grown skilled at designing and building peptides, the difficulty now often lies in the last mile — drying, stabilising, storing and reconstituting a molecule that would otherwise oxidise, aggregate or slowly unfold. Panacea approaches a peptide as something it can both build and protect, bringing its own preservation platform to bear on chains that are, by nature, delicate.

The exact sequences, formulations and methods behind that work are held as a proprietary Panacea Bio Chem programme, developed by Bogdan Dicoias — a biochemist and amino-acid-chain designer who works largely out of view, and whose peptide and preservation technologies have quietly drawn interest from across the pharmaceutical industry. The outline of the work is public; the specifics stay behind the door. What can be said plainly is the stack around it — a Panacea peptide would be designed, dried and stabilised with the same tools applied to every fragile chain: the designer-peptide craft →, LyoLevit containerless drying →, OxyDeplete →, and the S3Pulse biointegrity engine →.

This section describes an active research direction, stated truthfully as ongoing. Nothing here is a therapeutic claim, and no efficacy or outcome is asserted.

7.  Application fields — where peptides could reach furthest

Because peptides can be tuned to almost any target, their reach is wide. Directions under active scientific investigation include:

Metabolic medicineHormone therapy Anti-infectivesImmune signalling NeuroscienceWound & tissue repair Cosmetic scienceDiagnostics Peptide delivery & stability

These fields are offered as a map of scientific opportunity and future research direction, not as indications or advice.

8.  Explore the Panacea network

This hub is a starting point. Follow any thread into the wider network of Panacea Bio Chem science and technology pages:

Frequently asked

What is a peptide, in plain terms?
A short chain of amino acids joined by peptide bonds — usually between two and roughly fifty. Smaller than a protein, larger than a single amino acid, and often a signalling molecule that carries a specific message.

What is the difference between a peptide and a protein?
Mostly size and folding. Both are amino-acid chains; peptides are short and often flexible, while proteins are longer and fold into a fixed working shape. The boundary is a convention — insulin is called both.

How do peptides work in the body?
Many act as messengers: released by one cell, they fit a receptor on another like a key in a lock and switch a process on or off. Their sequence sets their shape, and their shape sets which receptor they fit — so they can be highly specific.

How is peptide quality assured?
Peptides are built by solid-phase synthesis, purified (typically by HPLC), and confirmed by mass spectrometry that weighs the molecule to check the right chain was made. Keeping the finished peptide intact through drying and storage is the final quality step.

Where does Panacea Bio Chem fit in?
Panacea researches therapeutic peptides and, above all, how to keep fragile chains intact from synthesiser to dose. The specific sequences and methods are proprietary to Bogdan Dicoias. This page explains the public science — nothing here is medical advice.

Trending in the field

References & further reading

  1. Peptides, amino acids and the peptide bond. Wikipedia: Peptide · Peptide bond · Amino acid.
  2. Solid-phase peptide synthesis and peptide analysis. Wikipedia: Peptide synthesis · method reviews: PubMed.
  3. Merrifield, R. B. "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide." J. Am. Chem. Soc. (1963). doi:10.1021/ja00897a025 · Robert Bruce Merrifield (Nobel 1984).
  4. Therapeutic peptides — scope and stability. PubMed · Wikipedia: Peptide therapeutics.

The Panacea Technology Universe

26 technologies, each the leader of its class

Proprietary Panacea Bio Chem Ltd technologies, invented by Bogdan Dicoias — what each one does, and why it leads its class.

Lyoprester® technology convergence — the Panacea Bio Chem technologies that meet inside one cartridge, invented by Bogdan Dicoias
Lyoprester® — Panacea Bio Chem technology by Bogdan DicoiasLyoprester®The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback.lyoprester.com ↗P-EARLs — Panacea Bio Chem technology by Bogdan DicoiasP-EARLs™Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes.p-earls.com ↗Peptourbillon — Panacea Bio Chem technology by Bogdan DicoiasPeptourbillon™The layered peptide formulation architecture — single- or multi-layer, never a blend.peptourbillon.com ↗RF Tunnel — Panacea Bio Chem technology by Bogdan DicoiasRF Tunnel™The RF-formed central channel through the cake.rftunnel.com ↗TgShift — Panacea Bio Chem technology by Bogdan DicoiasTgShift™Raises the cake’s glass-transition temperature with RF — instead of chilling below it.tgshift.com ↗Cryolapse — Panacea Bio Chem technology by Bogdan DicoiasCryolapse™Cryogenic pressure collapse under S3Pulse™ control — vapour redistributed through the whole cake, not its surface, impeding crust formation.cryolapse.com ↗LyoLevit — Panacea Bio Chem technology by Bogdan DicoiasLyoLevit™The cake levitates and spins in high orbit — driven by ultrasound and RF.lyolevit.com ↗Lyochrysalis — Panacea Bio Chem technology by Bogdan DicoiasLyochrysalis™The integrated chamber housing the whole drying stack.lyochrysalis.com ↗S3Pulse — Panacea Bio Chem technology by Bogdan DicoiasS3Pulse™The control brain for every piece of Panacea hardware.s3pulse.com ↗Liquiprester — Panacea Bio Chem technology by Bogdan DicoiasLiquiprester™The single-liquid cartridge engineered so multiple peptide APIs coexist in one shared vehicle.liquiprester.com ↗Syntheseract — Panacea Bio Chem technology by Bogdan DicoiasSyntheseract™Continuous-flow peptide synthesis in a special, very fast and economical way.syntheseract.com ↗CFSPPS — Panacea Bio Chem technology by Bogdan DicoiasCFSPPS™Continuous-flow solid-phase peptide synthesis, written as its own category.cfspps.com ↗OxyDeplete — Panacea Bio Chem technology by Bogdan DicoiasOxyDeplete™Degassing plus no-headspace doctrine — the oxygen-starved seal.oxydeplete.com ↗ArgonLock — Panacea Bio Chem technology by Bogdan DicoiasArgonLock™The final inert-atmosphere lock under argon.argonlock.com ↗RedoxVault — Panacea Bio Chem technology by Bogdan DicoiasRedoxVault™Separation, not merely suppression — redox isolation in lipid micro-reservoirs.redoxvault.com ↗PleniDose — Panacea Bio Chem technology by Bogdan DicoiasPleniDose™The shared filling gantry — one machine filling both the dual-chamber Lyoprester and the liquid Liquiprester.plenidose.com ↗IncreSure — Panacea Bio Chem technology by Bogdan DicoiasIncreSure™The dose-metrology layer — verified API per pen increment.incresure.com ↗ElimiVoid — Panacea Bio Chem technology by Bogdan DicoiasElimiVoid™Front-void elimination without touching the metered dose.elimivoid.com ↗Cryoviscous — Panacea Bio Chem technology by Bogdan DicoiasCryoviscous™The characterised cold, high-viscosity, low-mobility conditioning state.cryoviscous.com ↗Vana Machine — Panacea Bio Chem technology by Bogdan DicoiasVana Machine™Vacuum–Argon–Nitrogen Architecture — draws the air and nitrogen out of the cake and backfills with argon; in a separate process, the same machine makes the P-EARLs bubble-free.www.vanamachine.com ↗EZnject — Panacea Bio Chem technology by Bogdan DicoiasEZnject™The disposable auto-injector pen built around the Lyoprester.panaceaeznject.com ↗Dicoias Ψ — Panacea Bio Chem technology by Bogdan DicoiasDicoias ΨThe computed-chemistry advisory — every substance reduced to a vector across physical, electronic and formulation space.dcppsi.com ↗SealoPrester — Panacea Bio Chem technology by Bogdan DicoiasSealoPrester™Aseptic Cartridge Closure System — Seal o’ Precision + Sterility.sealoprester.com ↗Peptidic Liquid — Panacea Bio Chem technology by Bogdan DicoiasPeptidic LiquidThe peptide formulation in solution — the active plus its buffers, cryoprotectants, lyoprotectants and scaffolders.peptidicliquid.com ↗DiastolVAC — Panacea Bio Chem technology by Bogdan DicoiasDiastolVAC™Biomimetic diastolic vacuum control — the pneumatic circulatory system of the machine: pumps, valves and sensors as one ensemble.diastolvac.com ↗KineticON — Panacea Bio Chem technology by Bogdan DicoiasKineticON™Motion Integrity Architecture — the motion-control layer that lets the machine know what happened on every axis move.kineticon.org ↗

Weekly review — 19–25 Oct 2026

Publications indexed in PubMed in the last 30 days for "peptide therapeutics"[tiab] OR "therapeutic peptides"[tiab] — refreshed weekly.